Single Injection of Cross-Linked Hyaluronate in Knee Osteoarthritis: A 52-Week Double-Blind Randomized Controlled Trial

Background: to compare the 52-week effectiveness and safety between HYAJOINT Plus (HJP) and Durolane in knee osteoarthritis (OA) treatment. Methods: consecutive patients received a single injection of 3 mL HJP or Durolane. The primary outcome was a visual analog scale (VAS) pain measurement at 26 we...

Full description

Bibliographic Details

Published in:	Pharmaceutics
Main Authors:	Po-Yen Ko, Chung-Yi Li, Chia-Lung Li, Li-Chieh Kuo, Wei-Ren Su, I-Ming Jou, Po-Ting Wu
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Subjects:	osteoarthritis cross-linked hyaluronate knee viscosupplementation
Online Access:	https://www.mdpi.com/1999-4923/14/9/1783